Heavy chain deposition disease presenting with raised anti-GBM antibody levels; a case report
Abstract Background Monoclonal immunoglobulin deposition disease (MIDD) is a rare condition accounting for < 1% of histopathological diagnoses made on kidney biopsy1. The best outcomes are seen in those diagnosed and treated promptly, but delay to diagnosis is common with the largest series repor...
Main Authors: | Michael Turner, Anna Crawford, Claire Winterbottom, Oliver Flossmann, Bassam Alchi, Maria Soares, Umanath Bhandary |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12882-020-01837-2 |
Similar Items
-
Heavy chain deposition disease presenting with raised anti-GBM antibody levels; a case report
by: Turner, M, et al.
Published: (2020) -
Coexistence of Light- and Heavy-Chain Deposition Disease and Immunotactoid Glomerulopathy in a Patient with Multiple Myeloma: A Case Report
by: Yaoxian Liang, et al.
Published: (2022-03-01) -
Editorial: GBM stem cells and the brain tumor microenvironment
by: Yunqing Li, et al.
Published: (2023-02-01) -
Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report
by: Rio Noto, et al.
Published: (2017-04-01) -
A Rational Designed Novel Bispecific Antibody for the Treatment of GBM
by: Rui Sun, et al.
Published: (2021-06-01)